scispace - formally typeset
X

Xuemei Tong

Researcher at University of Pennsylvania

Publications -  8
Citations -  946

Xuemei Tong is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Medicine & Glycolysis. The author has an hindex of 4, co-authored 4 publications receiving 830 citations. Previous affiliations of Xuemei Tong include Shanghai Jiao Tong University.

Papers
More filters
Journal ArticleDOI

The molecular determinants of de novo nucleotide biosynthesis in cancer cells

TL;DR: This review will focus on recent progress in understanding how glucose and glutamine metabolism is redirected by oncogenes in order to support de novo nucleotide biosynthesis during proliferation and how metabolic reprogramming can be potentially exploited in the development of new cancer therapies.
Journal ArticleDOI

Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming.

TL;DR: In both primary cultures of cells from patients exhibiting blast transformation and in vivo xenograft tumors, use of oxythiamine, which can inhibit both the pyruvate dehydrogenase complex and transketolase, resulted in enhanced imatinib sensitivity of tumor cells.
Journal ArticleDOI

The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation

TL;DR: It is demonstrated that the expression of ChREBP can be induced in response to mitogenic stimulation and that the induction of Ch REBP is required for efficient cell proliferation, and that suppression ofChREBP led to a p53-dependent reduction in tumor growth.
Journal ArticleDOI

Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability

TL;DR: In this article , SIRT5 knockdown impairs the production of ribose-5-phosphate, which is essential for nucleotide synthesis, resulting in continuous and irreparable DNA damage and consequently leading to cell cycle arrest and enhanced apoptosis.